DEFINING TOMORROW'S VASCULAR STRATEGIES
×
Register now to R3i !
Your login
Your password
Confirm your password
Your email
I agree to receive the R3i newsletter
The Initiative

Prof. Michal Vrablik

Prof. Michal Vrablik
Charles University
Prague
 
Short Narrative Biography
 

Michal Vrablik M.D., Ph.D. is a Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the Czech Republic.
His main interests include preventive cardiology, clinical lipidology, CVD risk reduction strategies with special focus on very high-risk group (e.g. type 2 diabetes), and genetics of lipoprotein metabolism disorders.
 
He is the chairman of the Czech Atherosclerosis Society, member of board of the Czech Society of Internal Medicine and the chairman of the Czech Association of Preventive Cardiology of the Czech Society of Cardiology. He is the head of the National centre of the FH screening MedPed program.
 
He served as a member of the Executive Committee of the European Atherosclerosis Society between 2012 and 2016, currently he continues cooperation with EAS as a member of its Educational Platform Committee. He is a member of the editorial board of PCSK9 Forum. In 2018 he joined the steering committee of the International Lipid Expert Panel. He closely cooperates with the International Atherosclerosis Society being the chair of IAS Regional Federation for Europe since January 2019. He has served as a principal investigator and investigator in more than fifty research projects on familial dyslipidemias and cardiovascular disease risk and has participated in a number of international clinical trials.
 
Since 2010 Dr. Vrablik has co-organized International Atherosclerosis Research School endorsed by the EAS and IAS. He was a member of organizing committees of the 75th EAS congress in Prague in 2005 and the 12th Congress of European Federation of Internal Medicine in 2013. He served as the president of the 85th Congress of European Atherosclerosis Society held in Prague in 2017.
 
Dr. Vrablik has authored and co-authored more than 400 papers in peer-reviewed scientific journals. He is the sole author of three monographs and of 25 book chapters. He is also a member of editorial board as well as a reviewer for several national and international journals.